Search for Clinical Trial Results
Hyperammonemia - 13 Studies Found
Status | Study |
Recruiting |
Study Name: N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia Condition: Inborn Errors of Metabolism Date: 2009-02-12 Interventions: Drug: N-carbamylglutamate 100 mg/kg/day or 2.2 g/M2/day in 3-4 divided doses for 3 days |
Recruiting |
Study Name: Blood Sugars in Children With Idiopathic Seizures. Condition:
|
Completed |
Study Name: Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE) Condition:
Date: 2013-10-11 Interventions:
|
Completed |
Study Name: Fat and Sugar Metabolism During Exercise, With and Without L-carnitine in Patients With Carnitine Transporter Deficiency Condition: Carnitine Transporter, Plasma-membrane, Deficiency of Date: 2013-08-05 Interventions: Dietary Supplement: Break in L-carnitine treatment Levocarnitine oral tablet supplement at individual do |
Completed |
Study Name: Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides Condition: Carnitine Transporter Deficiency Date: 2005-09-14 Interventions: Other: Fasting blood and urine collection Not applicable no drugs dispensed |
Completed |
Study Name: Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD) Condition: Urea Cycle Disorders Date: 2009-07-24 Interventions: Drug: HPN-100 HPN-100 is a triglyceride that has a similar mechanism of action as NaPBA. It is a liquid |
Completed |
Study Name: Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders Condition: Urea Cycle Disorders Date: 2009-10-08 Interventions:
|
Completed |
Study Name: Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI Condition: Ornithine Transcarbamylase Deficiency Date: 2012-03-30 Interventions:
|
Completed |
Study Name: Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs) Condition: Urea Cycle Disorders Date: 2011-04-29 Interventions: Drug: HPN-100 HPN-100 is a pro-drug of PAA that combines with glutamine to provide an alternative vehicl |
Completed |
Study Name: Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders Condition: Urea Cycle Disorders Date: 2009-07-24 Interventions:
|